Amir Nashat, Director at FATE THERAPEUTICS INC (FATE), sold 124,010 shares at $22.53 ($2.8M) on 2019-07-31, disclosed to the SEC on 2019-08-02.
Open-market sale of $2.8M FATE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.53 | 206 | $5K | 0.2% |
| 2 | $22.53 | 302 | $7K | 0.2% |
| 3 | $22.53 | 586 | $13K | 0.5% |
| 4 | $22.53 | 30,045 | $677K | 24.2% |
| 5 | $22.53 | 586 | $13K | 0.5% |
| 6 | $22.53 | 30,045 |
| $677K |
| 24.2% |
| 7 | $22.53 | 302 | $7K | 0.2% |
| 8 | $22.53 | 206 | $5K | 0.2% |
| 9 | $22.53 | 204 | $5K | 0.2% |
| 10 | $22.53 | 581 | $13K | 0.5% |
| 11 | $22.53 | 29,782 | $671K | 24.0% |
| 12 | $22.53 | 299 | $7K | 0.2% |
| 13 | $22.53 | 299 | $7K | 0.2% |
| 14 | $22.53 | 29,782 | $671K | 24.0% |
| 15 | $22.53 | 581 | $13K | 0.5% |
| 16 | $22.53 | 204 | $5K | 0.2% |
| Total | $22.53 avg | 124,010 | $2.8M | 100% |
| Filing → |
| SRRK | BUY | 2022-06-24 | $6.2M | — | Filing → |
| MORF | SELL | 2021-05-25 | $20.4M | — | Filing → |
| MTCR | BUY | 2020-09-22 | $3.0M | — | Filing → |